Skip to main content

Table 2 Baseline demographics and clinical characteristics for severe enduring anorexia nervosa participants included in the present analyses, presented for each treatment group (real and sham) separately

From: A pilot study exploring the effect of repetitive transcranial magnetic stimulation (rTMS) treatment on cerebral blood flow and its relation to clinical outcomes in severe enduring anorexia nervosa

 

Real rTMS (n = 14)

Sham rTMS (n = 10)

Age [years] (mean ± SD)

28.79 ± 10.17

26.20 ± 8.19

Illness duration [years] (mean ± SD)

13.96 ± 11.58

11.70 ± 7.72

AN-R/AN-BP [n]

8 / 6

6 / 4

EDE-Q Global (mean ± SD)

3.95 ± 1.38

4.38 ± 0.76

BMI [kg/m2] (mean ± SD)

15.93 ± 1.67

16.47 ± 0.73

DASS-21 Depression (mean ± SD)

26.43 ± 10.14

26.40 ± 11.23

DASS-21 Anxiety (mean ± SD)

14.86 ± 8.80

16.40 ± 13.16

  1. Abbreviations: rTMS repetitive transcranial magnetic stimulation, SD standard deviation, AN-R anorexia nervosa restricting type, AN-BP anorexia nervosa binge-eating/purging type, EDE-Q Eating Disorder Examination Questionnaire, BMI body mass index, DASS-21 Depression, Anxiety and Stress Scale –Version 21